US Trends

what percentage of endometrial biopsies are cancerous

Most endometrial biopsies are not cancerous. Across large studies, roughly 3–5% of endometrial biopsies show endometrial cancer, and another small percentage (about 3–7%) show precancerous atypical hyperplasia or endometrioid intraepithelial neoplasia (EIN).

Quick Scoop

  • In big series of several thousand women who had an endometrial biopsy, about 1–4% were found to have endometrial cancer.
  • Precancerous changes (like atypical hyperplasia or EIN) add roughly another 3–7% of cases.
  • That means around 85–95% of biopsies show either benign causes (normal cycling endometrium, atrophy, polyps, benign hyperplasia, inflammation) or are non‑diagnostic.
  • In one study of 4,247 endometrial samples, only 1.34% were “complex hyperplasia with atypia and endometrial adenocarcinoma” combined, with another small fraction showing other hyperplasias.
  • A 2025 analysis of endometrial sampling found about 4.1% endometrial carcinoma and 6.8% EIN (a precancerous lesion) among women biopsied for suspected problems.

So, when people ask “what percentage of endometrial biopsies are cancerous,” a reasonable ballpark is:

About 3–5% show cancer, and another few percent show precancerous changes; the vast majority are benign.

Why the Percentages Vary

Different studies and clinics report different numbers because:

  1. Who is being biopsied:
    • Older, postmenopausal women with bleeding or high‑risk factors (obesity, PCOS, tamoxifen use, strong family history) have higher cancer rates in biopsy results.
 * Younger women or those biopsied for milder issues usually have much lower cancer rates.
  1. Reason for the biopsy (indication):
    • Postmenopausal bleeding is more strongly associated with endometrial cancer than, for example, irregular periods in a 30‑year‑old.
 * In a postmenopausal bleeding clinic, one study found cancer or atypical hyperplasia in about 6–7% of women who ended up needing a biopsy.
  1. Local practice and selection:
    • Some centers biopsy more conservatively; others only biopsy higher‑risk patients, so their percentage of cancers will naturally look higher.

What This Means If You’re Waiting on Results

If you or someone you know is waiting for an endometrial biopsy result:

  • Statistically, it is much more likely to be benign than cancer.
  • Even when something abnormal is found, many cases are precancerous changes that can often be treated effectively to prevent cancer from developing.
  • If the biopsy shows a lesion like complex atypical hyperplasia or EIN, doctors often recommend closer follow‑up or surgery because studies show a significant fraction of these cases already have or may progress to cancer if not managed.

Mini FAQ

  1. Is an endometrial biopsy a cancer screening test?
    • Not in average‑risk women. It is usually done when there is a symptom (like abnormal bleeding) or a risk factor that makes the doctor concerned.
  1. If my biopsy is benign, can cancer still appear later?
    • Yes, but the risk is low. Long‑term studies show that a small number of women with a benign biopsy later develop endometrial cancer, especially if strong risk factors are present, which is why follow‑up and risk‑factor control matter.
  1. Bottom line number to remember:
    • For most typical groups getting an endometrial biopsy, about 1 in 20 or fewer biopsies show cancer, and a similar or slightly smaller fraction show precancerous changes; the rest are benign.

Meta description (SEO):
Wondering what percentage of endometrial biopsies are cancerous? Recent studies suggest about 3–5% show endometrial cancer and a few more percent show precancerous changes, with most biopsies benign.

Information gathered from public forums or data available on the internet and portrayed here.